Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Change in Receivables (2020 - 2025)

Silence Therapeutics' Change in Receivables history spans 6 years, with the latest figure at -$30000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 104.91% to -$30000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.0 million, a 105.03% decrease, with the full-year FY2025 number at -$1.0 million, down 213.27% from a year prior.
  • Change in Receivables hit -$30000.0 in Q4 2025 for Silence Therapeutics, up from -$62000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for SLN hit a ceiling of $46.5 million in Q2 2021 and a floor of -$13.8 million in Q2 2023.
  • Historically, Change in Receivables has averaged $2.9 million across 5 years, with a median of -$11000.0 in 2025.
  • Biggest five-year swings in Change in Receivables: tumbled 3243.59% in 2023 and later soared 1158.72% in 2024.
  • Tracing SLN's Change in Receivables over 5 years: stood at -$2.5 million in 2021, then soared by 62.53% to -$920748.7 in 2022, then skyrocketed by 131.54% to $290429.5 in 2023, then surged by 110.38% to $611000.0 in 2024, then plummeted by 104.91% to -$30000.0 in 2025.
  • Business Quant data shows Change in Receivables for SLN at -$30000.0 in Q4 2025, -$62000.0 in Q3 2025, and $8000.0 in Q2 2025.